David Sheppard
Direttore/Membro del Consiglio presso Revona Bio Ltd.
Posizioni attive di David Sheppard
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Revona Bio Ltd.
 Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson. | Direttore/Membro del Consiglio | 05/04/2023 | - |
Storia della carriera di David Sheppard
Precedenti posizioni note di David Sheppard
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Direttore/Membro del Consiglio | 17/07/2019 | 09/07/2022 |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 2 |
Settori
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Health Technology |
Revona Bio Ltd.
Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson. | Commercial Services |
- Borsa valori
- Insiders
- David Sheppard
- Esperienza
